Related Experiment Video
Updated: Aug 18, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients
Munenori Haruta1, Shigeru Otsubo1,2, Yuriko Otsubo2
1Department of Clinical Engineering, Faculty of Human Care at Makuhari, Tohto University, 1-1 Hibino, Mihama-Ward, Chiba-City, Chiba-Prefecture 261-0021 Japan.
Insights
COVID-19 outcomes improved for hemodialysis patients in Japan during the 6th wave. Increased vaccination rates and advanced treatments, including neutralizing antibodies and molnupiravir, led to better prognoses and fewer critical cases.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- COVID-19 poses significant risks to hemodialysis patients.
- The 6th wave in Japan was primarily driven by the Omicron variant.
- Understanding clinical characteristics during different infection waves is crucial for patient management.
Purpose of the Study:
- To compare the clinical characteristics and outcomes of hemodialysis patients with COVID-19 between the 1st-5th waves and the 6th wave in Japan.
- To assess the impact of vaccination and new treatments on patient prognosis.
Main Methods:
- Retrospective cohort study comparing two groups of hemodialysis patients.
- Group 1: Patients admitted from January 2022 onwards (6th wave, n=53).
- Group 2: Patients admitted during the 1st-5th waves (n=47).
Main Results:
- The 6th wave group had significantly higher vaccination rates (96.2% vs 10.6%).
- Use of neutralizing antibodies and molnupiravir was more frequent in the 6th wave group.
- Critical COVID-19 disease was absent in the 6th wave group, compared to 21.3% in the earlier waves.
Conclusions:
- Hemodialysis patients in Japan experienced improved outcomes during the 6th COVID-19 wave.
- Increased vaccination coverage and advancements in antiviral treatments likely contributed to the better prognosis.
Background:
We examined the clinical characteristics of hemodialysis patients with COVID-19 during the 6th wave of infection (mainly Omicron variant) in Japan.
Methods:
Hemodialysis patients admitted in January 2022 and thereafter were grouped as the 6th wave group (n = 53), while others were grouped as the 1st-5th wave group (n = 47).
Results:
The proportion of vaccinations was significantly higher in the 6th wave group than in the 1st-5th wave group (96.2% vs 10.6%, p < 0.0001). Neutralizing antibody and molnupiravir were used more frequently in the 6th wave group (75.5% and 88.7%) than in the 1st-5th wave group (14.9% and 0%, both p < 0.0001). The critical disease was seen in 21.3% of the patients in the 1st-5th wave group and 0% in the 6th wave group (p < 0.001).
Conclusion:
The prognosis of hemodialysis patients in the 6th wave group was good. The vaccination and advances in the treatment may have contributed to the outcomes.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Dialysis
Acute Kidney Injury III: Clinical Manifestations

